## Abstract Complement activation via the alternative pathway by tumor cells was tested by rosette formation of human erythrocytes (HuE). Test cells were treated with C4‐deficient guinea‐pig serum (C4DS) in the presence of Mg^++^ and absence of Ca^++^, following which 10–30% of lymphoma cells and 1
Nonspecific activation of complement by leukemic cells
✍ Scribed by Toshikazu Shimbo; Junichi Yata; Hidechika Okada
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- French
- Weight
- 358 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Non‐specific activation of complement (NAC) on cell membranes via the alternative pathway was studied by using leukemic cells and cells from a generalized reticulohistiocytosis. The cells were treated with normal human serum in veronal‐buffered saline containing ethyleneglycoltetra‐acetate and Mg^++^. Since human erythrocytes (HuE) are known to adhere to complement‐reacted cell membranes in an immune adherence reaction, complement activation on the cell membrane was confirmed by the rosette formation of HuE which is due to the generation of C3b molecules on the cell membrane. Only cells from Schilling‐type acute monocytic leukemias and cells from a generalized reticulohistiocytosis possessed NAC ability. All other leukemic cells tested, as well as normal hematopoietic and lymphoreticular cells, were NAC‐negative. Furthermore, none of the mitogens tested generated NAC ability on normal peripheral blood lymphocytes.
📜 SIMILAR VOLUMES
Background: Procaspase 3 is a constitutive proenzyme that is activated by cleavage during apoptosis. The resulting enzyme is able to cleave several target proteins after the second aspartate of a DEVD sequence common to all the substrates of caspases 3 and 7 (DEVDase). Because active caspase 3 is a